
    
      We plan to recruit the patients who were pathologically confirmed with esophageal squamous
      cell carcinoma from the Oct 2014. The patients will be divided into two groups.Experimental
      group: Two cycles of cisplatin plus 5-fluorouracil concurrent radiotherapy.Control group:Four
      cycles of cisplatin plus 5-fluorouracil and concurrent radiotherapy.To evaluate the overall
      survival of the 2 group. Also observe the patient's progression-free survival, response rate,
      pathologic complete response rate and adverse events.
    
  